{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:23:02Z","timestamp":1785410582732,"version":"3.56.0"},"reference-count":34,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/02ks8qq67","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"Hungarian National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["FK138462"],"award-info":[{"award-number":["FK138462"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"Hungarian National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["150834"],"award-info":[{"award-number":["150834"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"Hungarian National Research, Development and Innovation Office","doi-asserted-by":"publisher","award":["EK\u00d6P-25-4-II-DE-59"],"award-info":[{"award-number":["EK\u00d6P-25-4-II-DE-59"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]},{"award":["FK138462"],"award-info":[{"award-number":["FK138462"]}],"id":[{"id":"https:\/\/ror.org\/03g2am276","id-type":"ROR","asserted-by":"publisher"}]},{"award":["150834"],"award-info":[{"award-number":["150834"]}],"id":[{"id":"https:\/\/ror.org\/03g2am276","id-type":"ROR","asserted-by":"publisher"}]},{"award":["EK\u00d6P-25-4-II-DE-59"],"award-info":[{"award-number":["EK\u00d6P-25-4-II-DE-59"]}],"id":[{"id":"https:\/\/ror.org\/03g2am276","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Fungi","JoF"],"abstract":"<jats:p>Objectives: The aim of our study was to investigate the in vitro activity and in vivo efficacy of rezafungin, anidulafungin, caspofungin and micafungin against Candida auris isolates belonging to clade V. Methods: Five clinical isolates were evaluated (IFRC2087, IFRC4050, MRL40, TMML616 and TMML617). Echinocandin MICs, according to CLSI M27-Ed4, and killing activities were determined in RPMI-1640. In the survival and fungal tissue burden experiments (heart, kidney and brain), neutropenic mice were infected intravenously (1 \u00d7 107 CFU\/mouse). Treatment was initiated 24 h post-infection with intraperitoneal dosing of 20 mg\/kg of rezafungin on days 1, 3 and 6 or once-daily dosing for 6 days with 3 mg\/kg of caspofungin, 5 mg\/kg of micafungin or 5 mg\/kg of anidulafungin. Results: MIC ranges of rezafungin, anidulafungin, caspofungin, and micafungin were 0.06\u20130.25, \u22640.03\u20130.12, 0.12\u20130.5 and \u22640.03\u20130.12 mg\/L, respectively. Growth in RPMI-1640 showed pseudohypha in all five isolates both at 30 \u00b0C and 37 \u00b0C, but hyphae were never observed. In contrast, echinocandin-treated yeasts at 37 \u00b0C showed small and large aggregates of blastoconidia at both 0.25 and 16 mg\/L echinocandin concentrations. The four echinocandins at \u22651 mg\/L were fungicidal only against isolate MRL40. All echinocandin regimens improved the survival in mice infected with isolates MRL40 and IFRC4050 (p-values were \u22640.0002 and 0.0006, respectively), but only rezafungin was effective against isolate TMML617 (p = 0.0049). All four echinocandins induced more than 4 log mean CFU\/gram decreases in the kidneys and hearts of mice infected with isolate MRL40 (p &lt; 0.001 for all echinocandins). Rezafungin and caspofungin significantly decreased the fungal kidney and heart burdens in mice infected with isolate TMML617. Against IFRC4050, rezafungin, anidulafungin and caspofungin significantly decreased the fungal burdens in the kidneys (p &lt; 0.05) and hearts (p &lt; 0.05\u20130.01). The fungal brain tissue burdens were always higher than 105 CFU\/gram. Histopathology showed large aggregates of pseudohyphae in the hearts, kidneys and brains in control mice. In echinocandin-treated mice, only blastoconidia were observed. Conclusions: In vitro activity and in vivo efficacy of the four echinocandins against the fifth clade of C. auris was echinocandin- and isolate-specific. Pseudohyphae production was common in controls, but not in echinocandin-treated mice. Rezafungin activity was comparable to or better than the three previously approved echinocandins.<\/jats:p>","DOI":"10.3390\/jof12080552","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:38:41Z","timestamp":1784889521000},"page":"552","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of Candida (Candidozyma) auris"],"prefix":"10.3390","volume":"12","author":[{"given":"D\u00e1vid","family":"Bal\u00e1zsi","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Doctoral School of Pharmaceutical Sciences, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3253-6080","authenticated-orcid":false,"given":"Jacques F.","family":"Meis","sequence":"additional","affiliation":[{"name":"Centre of Expertise in Mycology, Radboudumc and Canisius Wilhelmina Hospital, 6525 GA Nijmegen, The Netherlands"},{"name":"Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Excellence Center for Medical Mycology (ECMM), University of Cologne, 50923 Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Locke","sequence":"additional","affiliation":[{"name":"Elion Therapeutics, Inc., 1 Lincoln Street, Suite 30-120, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Udvarhelyi","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Doctoral School of Pharmaceutical Sciences, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"T\u00f3th","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Medical Microbiology, Clinical Centre, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lajos","family":"Forg\u00e1cs","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"K\u00f3sa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Clinical Centre, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3946-2424","authenticated-orcid":false,"given":"Ren\u00e1t\u00f3","family":"Kov\u00e1cs","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Medical Microbiology, Clinical Centre, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Majoros","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary"},{"name":"Medical Microbiology, Clinical Centre, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"ref_1","unstructured":"WHO (2022). Fungal Priority Pathogens List to Guide Research, Development and Public Health Action, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/cid\/ciw691","article-title":"Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses","volume":"64","author":"Lockhart","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","unstructured":"CDC (2026, April 01). Available online: https:\/\/www.cdc.gov\/fungal\/candida-auris\/c-auris-antifungal.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: An initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15585\/mmwr.mm6901a2","article-title":"Candida auris isolates resistant to three classes of antifungal medications\u2014New York, 2019","volume":"69","author":"Ostrowsky","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/myc.13655","article-title":"Whole genome sequencing analysis demonstrates therapy-induced echinocandin resistance in Candida auris isolates","volume":"66","author":"Spruijtenburg","year":"2023","journal-title":"Mycoses"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/myc.13396","article-title":"South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature","volume":"65","author":"Mirhendi","year":"2022","journal-title":"Mycoses"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11046-021-00605-6","article-title":"A chronic autochthonous fifth clade case of Candida auris otomycosis in Iran","volume":"187","author":"Safari","year":"2022","journal-title":"Mycopathologia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/myc.12886","article-title":"Candida auris otomycosis in Iran and review of recent literature","volume":"62","author":"Abastabar","year":"2019","journal-title":"Mycoses"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3201\/eid2509.190686","article-title":"Potential fifth clade of Candida auris, Iran, 2018","volume":"25","author":"Chow","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1080\/22221751.2022.2125349","article-title":"Confirmation of fifth Candida auris clade by whole genome sequencing","volume":"11","author":"Spruijtenburg","year":"2022","journal-title":"Emerg. Microbes Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100878","DOI":"10.1016\/S2666-5247(24)00101-0","article-title":"Detection and characterisation of a sixth Candida auris clade in Singapore: A genomic and phenotypic study","volume":"5","author":"Suphavilai","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/infdis\/jiae146","article-title":"Regulatory considerations in the approval of rezafungin (Rezzayo) for the treatment of candidemia and invasive candidiasis in adults","volume":"230","author":"Smith","year":"2024","journal-title":"J. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/jac\/dkz390","article-title":"In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae","volume":"74","author":"Locke","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e01626-16","DOI":"10.1128\/AAC.01626-16","article-title":"Pharmacokinetics of the novel echinocandin Cd101 in multiple animal species","volume":"61","author":"Ong","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(22)02324-8","article-title":"ReSTORE trial investigators. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): A multicentre, double-blind, double-dummy, randomised phase 3 trial","volume":"401","author":"Thompson","year":"2023","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e70114","DOI":"10.1111\/myc.70114","article-title":"Rezafungin utilisation in real life-FungiScope results from Europe and the United States","volume":"68","author":"Reinhold","year":"2025","journal-title":"Mycoses"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e70122","DOI":"10.1111\/myc.70122","article-title":"Efficacy and safety of rezafungin versus caspofungin for the treatment of candidemia and invasive candidiasis in a China cohort of a double-blind, randomised, phase 3 trial (ReSTORE China)","volume":"68","author":"Huang","year":"2025","journal-title":"Mycoses"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Kov\u00e1cs, R., T\u00f3th, Z., Locke, J.B., Forg\u00e1cs, L., Kardos, G., Nagy, F., Borman, A.M., and Majoros, L. (2021). Comparison of in vitro killing activity of rezafungin, anidulafungin, caspofungin, and micafungin against four Candida auris clades in RPMI-1640 in the absence and presence of human serum. Microorganisms, 9.","DOI":"10.3390\/microorganisms9040863"},{"key":"ref_20","unstructured":"Clinical and Laboratory Standards Institute (2017). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, CLSI. [4th ed.]. M27 Ed4."},{"key":"ref_21","unstructured":"CLSI (2022). Performance Standards for Antifungal Susceptibility Testing of Yeasts, Clinical and Laboratory Standards Institute. [3rd ed.]. CLSI Supplement M27M44S."},{"key":"ref_22","unstructured":"Redell, M. (2026, March 30). Proposal for Rezafungin Final CLSI Breakpoints vs. Candida Species. CLSI Antifungal Subcommittee Meeting Plenary Session. Melinta Therapeutics. Available online: https:\/\/clsi.org\/media\/epube0cq\/2024_january_ast_meeting_agenda_summary_minutes.pdf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1080\/22221751.2020.1771218","article-title":"Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model","volume":"9","author":"Borman","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bal\u00e1zsi, D., T\u00f3th, Z., Locke, J.B., Borman, A.M., Forg\u00e1cs, L., Balla, N., Kov\u00e1cs, F., Kov\u00e1cs, R., Amano, C., and Baran, T.I. (2024). In vivo efficacy of rezafungin, anidulafungin, caspofungin and micafungin against four Candida auris clades in a neutropenic murine bloodstream infection model. J. Fungi, 10.","DOI":"10.3390\/jof10090617"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11046-025-00963-5","article-title":"Pathogenicity evaluation on fluconazole-resistant Candida auris clade V in murine model","volume":"190","author":"Barough","year":"2025","journal-title":"Mycopathologia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e00189-16","DOI":"10.1128\/mSphere.00189-16","article-title":"Comparative pathogenicity of United Kingdom isolates of the emerging pathogen, Candida auris and other key pathogenic Candida species","volume":"18","author":"Borman","year":"2016","journal-title":"mSphere"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"iyab029","DOI":"10.1093\/genetics\/iyab029","article-title":"Clade-specific chromosomal rearrangements and loss of subtelomeric adhesins in Candida auris","volume":"218","author":"Welsh","year":"2021","journal-title":"Genetics"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e00151-20","DOI":"10.1128\/mSphere.00151-20","article-title":"Pseudohyphal growth of the emerging pathogen Candida auris is triggered by genotoxic stress through the S phase checkpoint","volume":"5","author":"Ruiz","year":"2020","journal-title":"mSphere"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41426-018-0187-x","article-title":"Filamentation in Candida auris, an emerging fungal pathogen of humans: Passage through the mammalian body induces a heritable phenotypic switch","volume":"7","author":"Yue","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s42003-025-09321-z","article-title":"Xenosiderophore transporter gene expression and clade-specific filamentation in Candida auris killifish (Aphanius dispar) infection","volume":"8","author":"Gifford","year":"2025","journal-title":"Commun. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Cosio, T., Pedretti, N., Spaggiari, L., Ruda, L.T., Kenno, S., Sabbatini, S., Pistoia, E.S., Comar, M., Monari, C., and Ardizzoni, A. (2025). Biological features, antimicrobial susceptibility and phenotypic characterization of Candidozyma auris CDC B11903 grown at different temperatures. J. Fungi, 11.","DOI":"10.20944\/preprints202507.1703.v1"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s40265-014-0286-5","article-title":"Echinocandin resistance, susceptibility testing and prophylaxis: Implications for patient management","volume":"74","author":"Perlin","year":"2014","journal-title":"Drugs"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Santana, D.J., Zhao, G., and O\u2019Meara, T.R. (2024). The many faces of Candida auris: Phenotypic and strain variation in an emerging pathogen. PLoS Pathog., 20.","DOI":"10.1371\/journal.ppat.1012011"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100794","DOI":"10.1016\/j.mmcr.2026.100794","article-title":"Isolation of a multidrug-resistant Candida auris Clade V from an asymptomatic acute myeloid leukemia patient in the intensive care unit","volume":"52","author":"Moslemi","year":"2026","journal-title":"Med. Mycol. Case Rep."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/8\/552\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:18:42Z","timestamp":1785039522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/12\/8\/552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jof12080552"],"URL":"https:\/\/doi.org\/10.3390\/jof12080552","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}